Mifepristone Access by Mail Continues as FDA Tells Louisiana Court Its Safety Review Should Finish by March 2027
The FDA told a Louisiana federal court that its mifepristone safety review should finish by March 2027. Telehealth and mail access remain in place for now.
Medical Daily ·